Literature DB >> 33532012

Effects of Curcumin Treatment in a Diabetic Neuropathic Pain Model of Rats: Involvement of c-Jun N-Terminal Kinase Located in the Astrocytes and Neurons of the Dorsal Root Ganglion.

Hanwool Park1, Jong-Hyuk Lee1, Ji Hoon Sim1, Jihoon Park1, Seong-Soo Choi1, Jeong Gil Leem1.   

Abstract

Curcumin (diferuloylmethane) is a major component of turmeric, which is isolated from the rhizomes of Curcuma longa L. from the family Zingiberaceae. It is used as a dietary pigment for curry and in traditional Indian medicine for its anti-inflammatory and attenuating pain effects. This study aimed to evaluate the beneficial effects of curcumin in a rat model of diabetic neuropathic pain. Additionally, we investigated the involvement of the phosphorylated form of c-Jun N-terminal kinase (pJNK) located in the neurons and astrocytes of the dorsal root ganglion (DRG). To induce diabetic neuropathic pain in rats, 50 mg/kg of streptozotocin (STZ) was intraperitoneally injected. After 4 weeks, rats were administered the vehicle, 10 mg/kg/day curcumin, or 50 mg/kg/day curcumin orally for 4 consecutive weeks. One day after the final drug administration, we performed behavioral tests to measure responses of rats to mechanical, heat, cold, and acetone-induced cold stimuli. After behavioral tests, pJNK expression in the DRG was evaluated using western blot assay and immunohistochemistry. Curcumin treatment for 4 consecutive weeks in STZ-induced diabetic neuropathic pain rats improved behavioral responses to mechanical, cold, and thermal stimuli. Increased pJNK expression in the astrocytes and neurons of the DRG in STZ-induced diabetic neuropathic pain rats was reduced by curcumin treatment for 4 consecutive weeks. We suggest that curcumin can be an option for the treatment of diabetes-related neuropathic pain, and one of the mechanisms that underlie the action of curcumin may involve pJNK expression in the astrocytes and neurons of the DRG.
Copyright © 2021 Hanwool Park et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33532012      PMCID: PMC7837777          DOI: 10.1155/2021/8787231

Source DB:  PubMed          Journal:  Pain Res Manag        ISSN: 1203-6765            Impact factor:   3.037


  44 in total

1.  Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo- controlled clinical trial.

Authors:  Sara Asadi; Mohammad Saeed Gholami; Fereydoun Siassi; Mostafa Qorbani; Kianoosh Khamoshian; Gity Sotoudeh
Journal:  Complement Ther Med       Date:  2019-02-28       Impact factor: 2.446

2.  Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled study.

Authors:  Krishna Adit Agarwal; C D Tripathi; Brij B Agarwal; Satish Saluja
Journal:  Surg Endosc       Date:  2011-06-14       Impact factor: 4.584

3.  Administration of Curcumin Alleviates Neuropathic Pain in a Rat Model of Brachial Plexus Avulsion.

Authors:  Wenji Xie; Wenqin Xie; Zhenming Kang; Changcheng Jiang; Naizhen Liu
Journal:  Pharmacology       Date:  2019-04-03       Impact factor: 2.547

4.  Curcumin ameliorates reserpine-induced pain-depression dyad: behavioural, biochemical, neurochemical and molecular evidences.

Authors:  V Arora; A Kuhad; V Tiwari; K Chopra
Journal:  Psychoneuroendocrinology       Date:  2011-05-25       Impact factor: 4.905

5.  A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance.

Authors:  Zhi-Ye Zhuang; Yeong-Ray Wen; De-Ren Zhang; Tiziana Borsello; Christophe Bonny; Gary R Strichartz; Isabelle Decosterd; Ru-Rong Ji
Journal:  J Neurosci       Date:  2006-03-29       Impact factor: 6.167

6.  Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats.

Authors:  Hanan Naeim Attia; Nouf Mohammed Al-Rasheed; Nawal Mohammed Al-Rasheed; Yousreya Ali Maklad; Amany A E Ahmed; Sanaa Abdel Baky Kenawy
Journal:  Behav Pharmacol       Date:  2012-04       Impact factor: 2.293

7.  Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model.

Authors:  Yong-Jing Gao; Jen-Kun Cheng; Qing Zeng; Zhen-Zhong Xu; Isabelle Decosterd; Xiaoyin Xu; Ru-Rong Ji
Journal:  Exp Neurol       Date:  2009-05-13       Impact factor: 5.330

8.  Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial.

Authors:  Sara Asadi; Mohammad Saeed Gholami; Fereydoun Siassi; Mostafa Qorbani; Gity Sotoudeh
Journal:  Phytother Res       Date:  2019-12-01       Impact factor: 5.878

9.  Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways.

Authors:  M Igarashi; H Wakasaki; N Takahara; H Ishii; Z Y Jiang; T Yamauchi; K Kuboki; M Meier; C J Rhodes; G L King
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Curcumin ameliorates neuropathic pain by down-regulating spinal IL-1β via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling.

Authors:  Shenbin Liu; Qian Li; Meng-Ting Zhang; Qi-Liang Mao-Ying; Lang-Yue Hu; Gen-Cheng Wu; Wen-Li Mi; Yan-Qing Wang
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.